Renaissance Technologies’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-219,328
| Closed | -$899K | – | 4701 |
|
|
2022
Q1 | $899K | Buy |
+219,328
| New | +$796K | ﹤0.01% | 2797 |
|
|
2021
Q4 | – | Sell |
-303,128
| Closed | -$1.1M | – | 4350 |
|
|
2021
Q3 | $1.1M | Buy |
+303,128
| New | +$1.23M | ﹤0.01% | 2494 |
|
|
2020
Q4 | – | Sell |
-339,213
| Closed | -$916K | – | 3835 |
|
|
2020
Q3 | $916K | Buy |
339,213
+101,685
| +43% | +$281K | ﹤0.01% | 2561 |
|
|
2020
Q2 | $653K | Sell |
237,528
-1,129,086
| -83% | -$3.15M | ﹤0.01% | 2765 |
|
|
2020
Q1 | $3.23M | Buy |
1,366,614
+221,907
| +19% | +$755K | ﹤0.01% | 1809 |
|
|
2019
Q4 | $5.38M | Buy |
1,144,707
+1,016,579
| +793% | +$4.16M | ﹤0.01% | 1806 |
|
|
2019
Q3 | $429K | Sell |
128,128
-196,200
| -60% | -$646K | ﹤0.01% | 2924 |
|
|
2019
Q2 | $1.07M | Sell |
324,328
-88,500
| -21% | -$256K | ﹤0.01% | 2646 |
|
|
2019
Q1 | $1.25M | Buy |
+412,828
| New | +$1.34M | ﹤0.01% | 2567 |
|
|
2018
Q1 | – | Sell |
-599,769
| Closed | -$1.19M | – | 3655 |
|
|
2017
Q4 | $1.19M | Sell |
599,769
-2,184,222
| -78% | -$4.75M | ﹤0.01% | 2595 |
|
|
2017
Q3 | $9.02M | Sell |
2,783,991
-678,478
| -20% | -$2.09M | 0.01% | 1397 |
|
|
2017
Q2 | $11.1M | Buy |
3,462,469
+309,900
| +10% | +$878K | 0.01% | 1216 |
|
|
2017
Q1 | $8.95M | Buy |
3,152,569
+293,228
| +10% | +$705K | 0.01% | 1313 |
|
|
2016
Q4 | $6.66M | Buy |
2,859,341
+185,000
| +7% | +$352K | 0.01% | 1483 |
|
|
2016
Q3 | $4.49M | Sell |
2,674,341
-43,511
| -2% | -$53.3K | 0.01% | 1665 |
|
|
2016
Q2 | $2.85M | Buy |
2,717,852
+486,683
| +22% | +$470K | 0.01% | 1977 |
|
|
2016
Q1 | $1.94M | Buy |
2,231,169
+845,731
| +61% | +$818K | ﹤0.01% | 2237 |
|
|
2015
Q4 | $1.68M | Buy |
1,385,438
+1,096,397
| +379% | +$1.53M | ﹤0.01% | 2215 |
|
|
2015
Q3 | $491K | Buy |
289,041
+106,100
| +58% | +$208K | ﹤0.01% | 2637 |
|
|
2015
Q2 | $381K | Buy |
+182,941
| New | +$444K | ﹤0.01% | 2803 |
|
|
2015
Q1 | – | Sell |
-85,970
| Closed | -$221K | – | 3405 |
|
|
2014
Q4 | $221K | Sell |
85,970
-59,758
| -41% | -$134K | ﹤0.01% | 2665 |
|
|
2014
Q3 | $267K | Buy |
+145,728
| New | +$318K | ﹤0.01% | 2506 |
|
Other funds holding ATRS
Renaissance Technologies's ATRS Position: Q2 2022 in Review
Renaissance Technologies sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 219,328 shares — an estimated $899K sold.
Renaissance Technologies first reported a position in ATRS in Q3 2014 and held it in 22 quarters. The position peaked at $11.1M in Q2 2017. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Renaissance Technologies reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Renaissance Technologies sold 219,328 Antares Pharma, Inc. shares in Q2 2022, an estimated $899K.
- Renaissance Technologies first reported a position in Antares Pharma, Inc. in Q3 2014 and held it in 22 quarters.
- Renaissance Technologies's Antares Pharma, Inc. position peaked at $11.1M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.